News

Knowledge of this disease is limited and mainly derives from small single-institution retrospective studies with contradictory results.

Joining up of EU's best expertise on this scale should benefit every year thousands of patients

Discovery of a dual role played by the enzyme phosphoglycerate kinase 1 (PGK1) may indicate a new therapeutic target for glioblastoma

The University of Milan is hosting a Master Course for clinical oncologists interested in advancing their skills on rare adult solid cancers

The ​European ​Commission, ​​the ​European ​Parliament, ​​experts ​and ​​patients ​putting sarcoma on the political agenda

New mouse model gives researchers insight into rare form of triple-negative breast cancer

Paolo Casali presents an update of the latest evidence on the best way to manage sarcomas and gastrointestinal stromal tumours

Information for generalists on late effects of anticancer chemotherapy that may affect quality of life.

Rare tumour registry created to improve the outcomes of children with rare tumours

The indication concerns the treatment of peripheral T-cell lymphoma

How can these cross-border healthcare structures improve the quality of care received by the almost half a million Europeans who are diagnosed with a rare cancer each year?

Glioblastoma patients with a protein called oncostatin M receptor on their tumours face a particularly poor prognosis